💊

Prescription Drugs

💊 Drugs 12,141 recalls

Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.

Feb 21, 2023 Prescription Drugs Nationwide View Details →

Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.

Mar 1, 2023 Prescription Drugs Nationwide View Details →

CGMP Deviations: recalling drug products following an FDA inspection.

Feb 7, 2023 Prescription Drugs View Details →

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Feb 13, 2023 Prescription Drugs Nationwide View Details →